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Edited by Frances ShannonAbstract Peritoneal injection of lipopolysaccharide (LPS) in-
creased the inﬂux of polymorphonuclear leukocytes and macro-
phages into the peritoneal cavity (PEC), with signiﬁcantly
higher cell numbers in the 4-1BB-deﬁcient (KO) mice than in
wild-type (WT) mice. The peritoneal macrophages of KO mice
contained less IL-10 transcripts and protein than those of WT
after LPS treatment, and immobilization of 4-1BB-Fc increased
the level of IL-10. Injection of IL-10 resulted in lower cell num-
bers into the PEC of KO mice, suggesting that lower level of IL-
10 is responsible for stimulated cell inﬂux in KO mice due to lack
of 4-1BB and 4-1BBL interaction.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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The generation of an immune response involves the activa-
tion of eﬀecter cells such as macrophages, neutrophils, and T
lymphocytes, and the subsequent production of cytokines
and reactive oxygen and nitrogen intermediates. Activated
macrophages play a central role in the regulation of immune
and inﬂammatory activities, as well as tissue remodeling. These
activities are mediated by complex processes involving macro-
phage products. Resident macrophages are the ﬁrst to encoun-
ter the pathogen in infected tissues, and neutrophils then
migrate from the circulation to infected sites. These neutro-
phils are short-lived and are soon replaced by the recruitment
of monocytes to the infected sites where they diﬀerentiate into
long-lived macrophages. The innate humoral immune system
produces a variety of chemotactic factors for neutrophils and
macrophages rapidly migrating from the blood to sites of
infection.
Interleukin (IL)-10, an inhibitory cytokine produced by T
cells, B cells, and monocytes/macrophages has diverse eﬀects.
It inhibits the synthesis of interferon (IFN)-c and IL-1a in
Th1 and CD8+ T cells [1], strongly down-regulates MHC class
II Ag expression [2], and inhibits H2O2 and nitric oxide pro-
duction by macrophages [3].*Corresponding author. Fax: +82 52 259 1694.
E-mail address: hschoi@mail.ulsan.ac.kr (H.-S. Choi).
1Supported by 2nd BK21 of UOU.
0014-5793/$32.00  2007 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2007.08.015Ligands of the tumor necrosis factor receptor (TNFR) fam-
ily are predominantly expressed on activated immune cells and
are distributed throughout the immune system, whereas the
corresponding receptors are more broadly distributed, being
found on a large variety of normal, virally infected, and cancer
cells [4,5]. Interactions between these ligands and the corre-
sponding receptors play important roles in development as
well as in regulating the immune system and inﬂammatory
responses. 4-1BB is strongly expressed on activated T cells,
but it is also expressed on a variety of cells including myeloid
cells [6]. 4-1BB ligand (4-1BBL) is also expressed on myeloid
lineage cells and on several leukemia cell lines [6,7]. The pat-
tern of expression of 4-1BB and 4-1BBL suggests that their
interaction could play a role in immune responses involving
myeloid cells. An interesting characteristic of this interaction
is that bi-directional signals are generated [8–13].
In the present study, we investigated the role of the 4-1BB/4-
1BBL interaction in macrophages during LPS-induced perito-
nitis, using 4-1BB-deﬁcient (KO) mice.2. Materials and methods
2.1. Reagents
Recombinant mouse 4-1BB-Fc fusion protein expressed in the hu-
man embryonic kidney cell line, HEK-293, and anti-annexin V FITC
conjugate were obtained from KOMED (Seoul, Korea), and BD Bio-
sciences (NJ, USA), respectively. Anti-CD11b FITC and PE conju-
gates, anti-GR1 PE conjugate, anti-F4/80 FITC conjugate, and anti
CD3 FITC and PE conjugates were from eBioscience (San Diego,
CA, USA). Antibodies against anti-4-1BBL (TKS-1) was from Immu-
nomics (Ulsan, Korea), and murine recombinant IL-10 protein, neu-
tralizing anti-IL-10 Ab, and biotinylated anti-IL-10 Ab were
purchased from R&D systems, Inc. (MN, USA). Lipopolysaccharide
(LPS), and TRI reagent were from Sigma Chemical Co. (St. Louis,
MN, USA). Fetal bovine serum (FBS) were purchased from Life Tech-
nologies (Grand island, NY, USA).2.2. Lipopolysaccharide peritonitis
LPS peritonitis was induced in 6-week-old BALB/c mice. 4-1BB+/+
(WT) and 4-1BB/ (KO) mice in the BALB/c background were pro-
vided by the University of Ulsan Immunomodulation Research Center
(IRC). The genotypes of oﬀspring were determined by Southern blot
analysis of DNA from tail biopsies. All mice were housed in the spe-
ciﬁc pathogen-free animal facility of the IRC and were handled in
accordance with the Institutional Animal Care and Use Committee
of the IRC. Standards were approved by the Institutional Animal Care
and Use Committee of the IRC. Mice received intraperitoneally (i.p.)
injections of LPS (1 mg/kg). Peritoneal exudate cells (PEC) were har-
vested at the indicated times with 5 ml of PBS containing 3 mM
EDTA. They were counted, and the numbers of viable cells in the dif-
ferent peritoneal subpopulations were determined by ﬂow cytometry
with a FACSCaliber (Becton Dickinson). Peritoneal lymphocytes,blished by Elsevier B.V. All rights reserved.
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ing to their diﬀerential forward and side scatter characteristics, and
counted. Alternatively, PEC were incubated with the culture superna-
tant of an anti-mouse Fcc mAb-producing B cell hybridoma, 2,4G2,
for 20 min to block nonspeciﬁc binding of mAb and washed. They
were stained with saturating amounts of FITC-, or PE-conjugated
CD3, B220, CD11b, GR-1, and F4/80 mAb. In some experiments, cells
were plated in a 100 mm tissue culture dish and allowed to adhere for
2 h at 37 C in a humidiﬁed atmosphere of 95% air and 5% CO2. Non-
adherent and adherent cells were then separated.2.3. Macrophage depletion
Multilamellar liposomes containing phosphate-based saline or
clondronate were purchased from ClondronateLiposomes (Vrije Uni-
versiteit, Amsterdam, Netherlands). Mice were treated (i.p.) with
200 ll of liposome for three consecutive days. LPS (1 mg/kg) wasFig. 1. Inﬂux of cells into the PEC after LPS-induced acute inﬂammation. PE
anti-CD11b, anti-GR-1, and anti-F4/80 mAb, and analyzed by FACS Calib
cells were calculated from the percentage of the cells among the total peritone
increases in the numbers of cells in the KO mice were statistically signiﬁcant (
LPS injection, stained with anti-GR-1, anti-F4/80, and anti-annexin V mAb
absolute numbers of cells were calculated from the percentage of the cells
deﬁcient (black bar) mice. No signiﬁcant diﬀerences were obtained between
intraperitoneally injected 4 h before LPS injection. PEC were obtained 15
increases in the number of cells in the TKS-1- treated WT (horizontal lined ba
compared with the rat IgG-treated WT mice (white bar) (*, P < 0.05; **, P <
mice for each group, and the data are representative of three separate experadministered i.p. 24 h after the last liposome administration. Peritoneal
cavities were lavaged 15 h later.
2.4. ELISA
Adherent peritoneal macrophages were incubated in 24-well plates
(106 cells/well) with indicated conditions. IL-10 levels in the culture
supernatants were determined by sandwich ELISA using anti-mouse
IL-10 mAb as capture Ab in combination with biotinylated anti-mouse
IL-10 Ab as detection Ab.
2.5. RNA isolation and RT-PCR
Expression of 4-1BB, 4-1BBL, IL-10, and GAPDH mRNA was as-
sessed by RT-PCR analysis. RNA was isolated from the above men-
tioned peritoneal macrophages using TRI reagent. Total RNA was
used for cDNA synthesis by the reverse transcriptase supplied with
the cDNA synthesis kit (Invitrogen, San Diego, CA, USA). cDNA
was ampliﬁed by PCR for 35 cycles (4-1BB, and 4-1BBL,), 32 cyclesC were obtained at the indicated time after LPS injection, stained with
ur (A; CD11b+GR-1+, B; CD11b+F4/80+). The absolute numbers of
al cells for wild type (WT) (s) and 4-1BB-deﬁcient (KO) () mice. The
**, P < 0.01; ***, P < 0.001, n = 5). C; PEC were obtained at 15 h after
, and analyzed by FACS Calibur (GR-1+AV+ or F4/80+AV+). The
among the total peritoneal cells for wild type (white bar) and 4-1BB-
WT and KO mice. TKS-1 (200 lg/mice) or rat IgG (200 lg/mice) were
h after LPS injection (D; CD11b+GR-1+, E; CD11b+F4/80+). The
r) and rat-IgG-treated KO mice (black bar) were statistically signiﬁcant
0.01, ***, P < 0.001, n = 5). The vertical bars are the means ± S.D. of 5
iments.
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ers: 4-1BB, 5 0-CAGAACTCCTGTGATAACTGT-30 (forward) and
5 0-CCCGGTCTTAAGCACAGACCT-3 0 (reverse); 4-1BBL, 5 0-GAG-
CCTCGGCCAGCGCTCAC-3 0 (forward) and 5 0-GATAGTTCTCA-
TTCCCATGG-3 0 (reverse); mouse IL-10 5 0-CCCTGGGTGAGAAG-
CTGAAG-30 (forward) and 5 0-GGAAGAACCCCTCCCATCAT-3 0
(reverse); mouse GAPDH, 5 0-ACCACAGTCCATGCCATCAC-3 0
(forward) and 5 0-TCCACCACCCTGTTGCTGTA-3 0 (reverse). Each
cycle consisted of 30 s of denaturation at 94 C, 30 s of annealing at
60 C, and 30 s of extension at 72 C. GAPDH was used as internal
control. The sizes of the PCR products for mouse 4-1BB, 4-1BBL,
IL-10, and GAPDH were 378, 623, 526, and 452 bp, respectively.2.6. Electrophoretic mobility shift assay (EMSA)
Adherent peritoneal macrophages were incubated in plates (107 cells)
with indicated conditions, and nuclear extracts were prepared. NF-jB-
binding studies were performed using double-stranded oligonucleotides
(Santa Cruz Biotechnology, Santa Cruz, CA, USA) containing an NF-
jB consensus binding site. The oligonucleotide or a variant was end-la-
beled with [c-32P] ATP using T4 polynucleotide kinase (Promega, Mad-
ison, WI, USA). Five microgram of each nuclear extract was incubated
at 30 C for 20 min with 1 ng of 32P-labeled NF-jB probe in 10 ll of
binding buﬀer containing 1 lg of poly (dI Æ dC), 15 mM HEPES, pH
7.6, 80 mM NaCl, 1 mM EGTA, 1 mM dithiothreitol, and 10% glyc-
erol. DNA–protein complexes were visualized by electrophoresis on a
native 5% polyacrylamide gel, vacuum-drying and autoradiography
using an intensifying screen at 80 C.Fig. 2. Role of macrophages in cell inﬂux after LPS-induced acute
inﬂammation. Mice were pretreated with liposomes encapsulating
saline or clodronate for 3 d before LPS injection. PEC were obtained
15 h after LPS injection, stained with anti-CD11b, anti-GR-1, and
anti-F4/80 mAb, and analyzed (A; CD11b+ GR-1+). The absolute2.7. Statistical analysis
All values are expressed as means ± S.E. Student’s t-test was used to
evaluate diﬀerences between samples of interest and their respective con-
trols. A P value of less than 0.05 was considered statistically signiﬁcant.numbers of cells were calculated from the percentage of the cells in the
total peritoneal cell population in WT (white bar) and KO mice (black
bar). The cell numbers in the KO mice were signiﬁcantly higher than in
the WT (*, P < 0.05, n = 4), whereas there was no signiﬁcant diﬀerence
between macrophage-depleted WT and KO mice. Depletion of resident
macrophages resulted in signiﬁcant decreases of CD11b+GR-1+ in
both of WT and KO mice (**, P < 0.01, n = 4). B. Expression of 4-
1BBL in peritoneal macrophages. Peritoneal macrophages from KO
and WT mice were prepared from 7-week-old mice as described in
Section 2. Total RNA was extracted and subjected to RT-PCR
analysis. Similar results were obtained in three independent experi-
ments.3. Results
3.1. Cell inﬂux into the peritoneal cavity of 4-1BB-deﬁcient mice
after lipopolysaccharide stimulation
We analyzed cell inﬂux in the peritoneal cavities of wild-type
(WT) and KO mice after exposure to the inﬂammatory stimu-
lus of LPS. Peritoneal injection of LPS increased the inﬂux of
polymorphonuclear leukocytes (PMN, CD11b+GR-1+) and
macrophages (CD11b+F4/80+) into the peritoneal cavity
(PEC). As shown in Fig. 1A, the number of PMN in the
PEC peaked at 15 h after LPS injection and the numbers of
PMN in the KO mice were higher than in the WT mice. Similar
results were obtained for the number of macrophages in the
PEC (Fig. 1B). Few CD3+ T lymphocytes were found, and
there was no signiﬁcant diﬀerence between the numbers of
these cells in the two strains of mice (results not shown). To
examine whether the lack of 4-1BB leads to changes in apop-
tosis, the numbers of annexin V-positive cells were determined.
As shown in Fig. 1C, there was no signiﬁcant diﬀerence in
apoptosis of GR-1+ or F4/80+ cells between WT and KO mice
after LPS stimulus. Injection of anti-4-1BBL Ab (TKS-1),
which blocks the interaction between 4-1BB and 4-1BBL,
together with the LPS, increased the numbers of PMN and
macrophages in the PEC of WT mice (Fig. 1D and E). Both
sets of results suggest that blocking the 4-1BB and 4-1BBL
interaction increases PMN and macrophage inﬂux after LPS-
induced stimulation.3.2. Speciﬁcity of macrophage depletion for the 4-1BB and 4-
1BBL interaction
4-1BB is induced on T cells that are activated by TCR sig-
naling, but it is expressed constitutively on myeloid lineagecells [6]. We depleted the resident peritoneal macrophages
using liposomes containing clondronate to investigate whether
they are responsible for the inﬂux of PMN after LPS exposure.
Since few macrophages were found in the PECs of WT and
KO mice after macrophage depletion (results not shown), only
the numbers of PMN were analyzed. Depletion of the resident
macrophages resulted in a signiﬁcant decrease in the number of
PMN in both of WT and KO mice, with no signiﬁcant diﬀer-
ence between them (Fig. 2A). This suggests that the macro-
phages in the PEC are responsible for the increased cell
inﬂux into the KO mice after LPS treatment. Expression of
4-1BB and 4-1BBL in the peritoneal macrophages was con-
ﬁrmed by RT-PCR. Both 4-1BB and 4-1BBL were expressed
in the macrophages of WT mice, and 4-1BBL was expressed
in those of the KO mice (Fig. 2B).
3.3. Decreased production of IL-10 by macrophages in 4-1BB-
deﬁcient mice after acute inﬂammation of the peritoneal
cavity
As stated earlier, cell inﬂux into the PEC of the KO mice was
maximal 15 h after LPS stimulation. It seemed possible that,
after the LPS treatment, the 4-1BB and 4-1BBL interaction
induces macrophages to produce factors that inhibit cell inﬂux
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1BBL interaction increases IL-10 in RANKL-stimulated bone
marrow-derived macrophages [14]. To see whether IL-10 levels
were involved in the eﬀect of 4-1BB deﬁciency on cell inﬂux of
PEC, we compared the lavage ﬂuids of PEC in WT and KO
mice at 15 h after LPS stimulation. As shown in Fig. 3A, IL-
10 production in the WT mice was higher than in the KO mice.
Moreover, anti-4-1BBL Ab reduced the amount of IL-10.
Next, we examined whether the macrophages of the WT and
KO mice are responsible for the diﬀerent levels of IL-10 accu-
mulated in response to LPS. As shown in Fig. 3B, the perito-
neal macrophages of the KO mice contained less IL-10 mRNA
than did those of WT mice after LPS treatment. We also mea-
sured IL-10 in the supernatants of peritoneal macrophages 5
and 15 h after LPS treatment. As shown in Fig. 3C, peritoneal
macrophages from the KO mice secreted less IL-10 in response
to LPS, suggesting that these macrophages are responsible for
the diﬀerence in levels of IL-10 in response to LPS.
Since both 4-1BB and 4-1BBL are expressed by macro-
phages they could activate a signaling pathway via 4-1BBL
[13] in response to LPS. To exclude indirect eﬀects via 4-
1BB, we examined the eﬀect of 4-1BB-Fc on IL-10 production
in peritoneal macrophages from the KO mice. As shown inFig. 3. Detection of IL-10 in the PEC and in peritoneal macrophages in res
intraperitoneally injected 4 h before LPS. PEC were obtained 15 h after LPS
levels in response to TKS-1 treatment of WT (horizontal lined bar) or rat IgG
rat IgG-treated WT mice (white bar) (*, P < 0.05; **, P < 0.01, n = 5). (B) Pe
plates (106 cells/well) in the presence of LPS (100 ng/ml) for the indicated tim
Peritoneal macrophages from KO (black bar) and WT mice (white bar) were i
ml) for 5 and 15 h and supernatant IL-10 was measured by ELISA. IL-10 leve
compared to those from KO mice in response to LPS for 5 and 15 h (**, P <
were incubated in 6-well plates (106 cells/well) immobilized with human IgG
times. Total RNA was extracted and subjected to RT-PCR analysis. (E) Perit
incubated in 6-well plates (106 cells/well) immobilized with human IgG (IgG) o
LPS for 8 h. The levels of IL-10 in the culture supernatants were measured
immobilized peritoneal macrophages were statistically signiﬁcant for both thFig. 3D, immobilized 4-1BB-Fc increased the level of IL-10
transcripts in the absence of 4-1BB, thus eliminating the possi-
bility that 4-1BB-Fc acts by competition with endogenous
membrane-bound 4-1BB. We measured the increase in produc-
tion of IL-10 caused by 4-1BB-Fc in LPS-stimulated peritoneal
macrophages by ELISA. As shown in Fig. 3E, IL-10 was
increased in the macrophages stimulated by immobilized
4-1BB Fc.
3.4. Involvement of IL-10 in the recruitment of macrophages and
PMN after LPS-induced acute inﬂammation
We tested whether the reduced level of IL-10 was responsible
for the increased recruitment of macrophages and PMN in the
PECs of KO mice after LPS-induced acute inﬂammation. To
this end, we examined the eﬀect of in vivo administration of
IL-10 on the accumulation of macrophages and PMN in the
KO mice. As shown in Fig. 4A, B, administration of IL-10
lowered the numbers of macrophages and PMN in the PEC
of the KO mice. This eﬀect was greater for macrophages than
for PMN and also greater in the KO mice than in the WT
mice. These results suggest that the level of IL-10 is lower in
the PEC of the KO mice, and that the lower level of IL-10
plays a key role in the increased recruitment of macrophagesponse to LPS. (A) TKS-1 (200 lg/mice) or rat IgG (200 lg/mice) was
injection, and the lavage ﬂuid was subjected to ELISA for IL-10. IL-10
-treated KO mice (black bar) was signiﬁcantly increased compared to
ritoneal macrophages from KO and WT mice were incubated in 6-well
es. Total RNA was extracted and subjected to RT-PCR analysis. (C)
ncubated in 6-well plates (106 cells/well) in the presence of LPS (100 ng/
ls of peritoneal macrophages from WT mice was signiﬁcantly increased
0.01, ***, P < 0.001, n = 3). (D) Peritoneal macrophages from KO mice
or 4-1BB-Fc protein (5 lg/ml) in the presence of LPS for the indicated
oneal macrophages from KO (black bar) and WT mice (white bar) were
r 4-1BB-Fc protein (Fc) (5 lg/ml) (oblique-lined bar) in the presence of
by ELISA. The diﬀerences between the human IgG- and 4-1BB-Fc-
e WT and KO mice (***, P < 0.001, n = 3).
Fig. 4. Eﬀects of IL-10 injection on cell inﬂux after LPS-induced acute inﬂammation. IL-10 (1 lg/mice) was injected intraperitoneally 24 h before
LPS injection. PEC were obtained 15 h after LPS injection, stained with anti-CD11b, anti-GR-1, and anti-F4/80 mAb, and analyzed (A; CD11b+F4/
80+, B; CD11b+GR-1+). The absolute numbers of cells were calculated from the percentage of the cells in the total peritoneal cells in the WT and
KO mice. The cell numbers in the KO mice were signiﬁcantly higher than in the WT mice (**, P < 0.01, ***, P < 0.001, n = 5). Injection of IL-10
resulted in a signiﬁcant decrease of CD11b+GR-1+ cells in the KO mice (*, P < 0.05, n = 5), whereas no signiﬁcant diﬀerence was found in the WT.
Injection of IL-10 resulted in signiﬁcant decreases of CD11b+F4/80+ in both of WT (white bar) and KO mice (black bar) (**, P < 0.01, ***,
P < 0.001, n = 5). The numbers above the histograms are ratios of the cell numbers in the groups treated with IL-10 to those treated with PBS. Data
are means ± S.D., and are representative of three separate experiments. (C) Eﬀect of IL-10 on NF-jB activation. Peritoneal macrophages from WT
and KO mice were stimulated with LPS (100 ng/ml) for 1 h in the presence (lanes 3 and 5) or absence (lanes 2 and 4) of IL-10 (10 ng/ml) in plates
immobilized 4-1BB-Fc (5 lg/ml) (lanes 2 and 3; WT, lanes 4 and 5; KO). A variant NF-jB oligomer (lane 1) were used as a negative control.
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production of IL-10 was mediated through modulating NF-
jB activation. By EMSA, exogenously added IL-10 decreased
LPS-induced DNA binding of NF-jB, but there was no signif-
icant diﬀerence of NF-jB activation between macrophages
from WT and KO mice (Fig. 4C).4. Discussion
We have demonstrated that inﬂux of PMN and macro-
phages into the PEC after LPS stimulation is greater in 4-
1BB-deﬁcient (KO) mice than in WT mice. Anti-4-1BBL Ab
treatment of WT mice also resulted in greater cell inﬂux as well
as lower levels of IL-10 in PEC. These ﬁndings indicate that
blocking the 4-1BB and 4-1BBL interaction increases the inﬂux
of PMN and macrophages after LPS stimulation, and that IL-
10 levels are inversely related to the extent of cell inﬂux. IL-10
production in WT mice was signiﬁcantly higher than in KO
mice, and the peritoneal macrophages of KO mice had lower
levels of IL-10 at the mRNA and protein levels than did those
of WT mice after LPS treatment, suggesting that the peritoneal
macrophages of WT and KO mice are responsible for the dif-
ferent levels of IL-10 in the PEC after LPS stimulus.
The stimulation of cell inﬂux could be due to an increase of
positive regulators of cell accumulation or a decrease of nega-
tive regulators. We previously showed that 4-1BB aﬀects osteo-
clastogenesis induced by receptor activator of NF-jB ligand,
another member of the TNFR family, by modulating the level
of IL-10 in bone marrow-derived macrophages [14]. IL-10,
whose level is regulated by macrophages [15], has been shown
to reduce PMN accumulation in experimental inﬂammation
and to inhibit the production of proinﬂammatory cytokines
[16]. In addition, Siewe et al. [17] demonstrated that a deﬁ-
ciency of IL-10 in macrophages and neutrophils augments
the inﬂammatory inﬁltration in response to LPS. IL-10-deﬁ-
cient mice are sensitive to septic shock following administra-tion of 20-fold lower doses of LPS than are needed in WT
mice [18]. These results indicate that IL-10 acts as a negative
regulator during inﬂammation. IL-10 also induces mitochon-
drial apoptosis cascade in macrophages [19]. However, our
data showed no diﬀerence of apoptosis in PEC of WT and
KO mice, suggesting that increased cell inﬂux in PEC of KO
mice could not be due to low level of apoptosis. We found
above that exogenously added IL-10 decreased cell inﬂux,
especially of macrophages, in response to LPS in both of
WT and KO PEC, but that the eﬀect was greater in the absence
of 4-1BB. This indicates that the 4-1BB and 4-1BBL interac-
tion plays a role in LPS-induced cell inﬂux, and that the
enhanced cell inﬂux in KO mice is due to the lower level of
IL-10. Although the involvement of NF-jB in IL-10 action
has been controversial, IL-10 has been demonstrated to inhibit
the activity of NF-jB in human monocytes [20], but NF-jB
activation has not been involved in IL-10 expression [21].
Our result also showed that exogenously added IL-10 inhibited
LPS-induced NF-jB DNA binding in peritoneal macrophages,
but no signiﬁcant diﬀerence of NF-jB activation was found
between WT and KO macrophages.
The role of the 4-1BB and 4-1BBL interaction has been stud-
ied using 4-1BB-KO and 4-1BBL-transgenic mice [22,23]. The
absence of 4-1BB resulted in higher numbers ofmyeloid progen-
itor cells and their more rapid turnover in the bonemarrow [22].
4-1BBL transgenic mice that expressed 4-1BBL constitutively in
antigen presenting cells showed splenomegaly, with increased
numbers of macrophage lineage cells and defects in antigen pre-
sentation [23]. These observations suggest that myeloid lineage
cells depend on the 4-BB–4-1BBL interaction for their proper
functioning. The crucial role of 4-1BBL ligation was demon-
strated by Saito et al. [12], who showed that immobilization of
4-1BB accelerates the proliferation of bone marrow cells. Liga-
tion of 4-1BBL also activates dendritic cells leading to IL-12
production [11], and results in increased apoptosis of activated
monocytes [8]. Our previous studies also showed that cross-
linking of 4-1BBL leads to high levels of IFN-b and results in
4360 H.-H. Shin et al. / FEBS Letters 581 (2007) 4355–4360inhibition of osteoclastogenesis in bonemarrow-derivedmacro-
phages [13]. Our results [13] and those of Saito et al. [12] indicate
that reverse signaling through 4-1BBL inhibits osteoclast for-
mation from monocyte/macrophage lineage cells. The abnor-
mal stimulation of cell inﬂux in KO mice could be, in
principle, due to the lack of 4-1BBL-mediated signals or some
indirect mechanism. However, the former appears to be more
plausible since immobilized 4-1BB-Fc increased IL-10 expres-
sion even in the absence of 4-1BB. High secreted levels of 4-
1BB are found in the sera of patients with rheumatic arthritis
[24,25], suggesting a role of 4-1BBL-mediated signals in the
pathogenesis of chronic inﬂammation.
Taken together our ﬁndings show that stimulation of cell in-
ﬂux by peritoneal macrophages is increased in the absence of
4-1BB, a member of the TNFR family. We have presented evi-
dence that 4-1BB aﬀects cell inﬂux after LPS-induced acute
inﬂammation by modulating the level of IL-10 in peritoneal
macrophages. Further study of the 4-1BB and 4-1BBL interac-
tion in myeloid lineage cells should clarify the role of 4-1BB in
modulating innate immunity, and provide a rational for its use
as a therapeutic agent in inﬂammation.Acknowledgements: This work was supported by the SRC fund to the
IRC, University of Ulsan, from KOSEF and the Korean Ministry of
Sciences and Technology, and by the Research Fund of the University
of Ulsan.
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